TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT05156450 · UNKNOWN

Trial details

NCT number: NCT05156450
Sponsor: West China Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Prostatic Neoplasms, Castration-Resistant Drug Therapy, Combination

Start date: 2022-01-01
Primary completion: 2023-10-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.